Medical device company Sygnis has unveiled its TruePrime Single Cell WGA Kit V2 for whole genome amplification (WGA) from a broader range of cell type for an extended application.

The device is based on Sygnis’ patented TruePrime technology and is independent of the requirement of random synthetic primers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The DNA amplification technology features a combination of proteins which works together to amplify the smallest amounts of DNA.

"The DNA amplification technology features a combination of proteins which works together to amplify the smallest amounts of DNA."

Sygnis CEO and CFO Pilar de la Huerta said: “Our newly launched TruePrime Single Cell WGA V2 Kit, once again, proves our innovation strength and our commitment to develop products with superior features addressing urgent needs in molecular biology, especially in areas such as next generation sequencing and single cell analysis.

“We make good progress in establishing ourselves as a global leader in the development and commercialisation of innovative tools for processing genetic information for a multitude of applications in fast growing markets such as human genetics, oncology, molecular diagnostics and personalised medicine.”

See Also:

The easy to use TruePrime Single Cell WGA V2 Kit operates sensitively and works with all commonly used next generation sequencing (NGS) platforms such as Illumina and IonTorrent.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The kit also promotes new lysis conditions enabling WGA from a broader range of cell types and at the same time increase the number of applications.

Lysis is considered important particularly in single cell analysis because of the limited sample volumes.

The kit includes human genomic DNA as an internal positive control encompassing the overall amplification process.